PDF(Pubmed)
Abstract：
This commentary highlights the scientific history of the NIH-Moderna COVID-19 vaccine and corroborates Sarpatwari\'s theme of private capture of value created by the public. The commentary also identifies missteps by the Trump and Biden Administrations and offers policy recommendations: better contracts with and incentives for pharmaceutical manufacturers and a not-for-profit \"public option\" for pharmaceutical development.
摘要：
这篇评论强调了NIH-ModernaCOVID-19疫苗的科学历史，并证实了Sarpatwari的主题，即私人获取公众创造的价值。评论还指出了特朗普和拜登政府的失误，并提供了政策建议：与制药商签订更好的合同和激励措施，以及为制药开发提供非营利性的“公共选择”。
